John R. Pinion II
2019
In 2019, John R. Pinion II earned a total compensation of $3.4M as Chief Quality Officer and Executive Vice President, Translational Sciences at Ultragenyx Pharmaceutical, a 111% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $205,490 |
---|---|
Option Awards | $923,578 |
Salary | $447,690 |
Stock Awards | $1,756,300 |
Other | $37,472 |
Total | $3,370,530 |
Pinion received $1.8M in stock awards, accounting for 52% of the total pay in 2019.
Pinion also received $205.5K in non-equity incentive plan, $923.6K in option awards, $447.7K in salary and $37.5K in other compensation.
Rankings
In 2019, John R. Pinion II's compensation ranked 3,632nd out of 13,971 executives tracked by ExecPay. In other words, Pinion earned more than 74.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,632 | 74th |
Manufacturing | 1,312 | 77th |
Chemicals And Allied Products | 456 | 79th |
Drugs | 382 | 80th |
Pharmaceutical Preparations | 287 | 80th |
Pinion's colleagues
We found four more compensation records of executives who worked with John R. Pinion II at Ultragenyx Pharmaceutical in 2019.
2019
Emil Kakkis
Ultragenyx Pharmaceutical
Chief Executive Officer
2019
Shalini Sharp
Ultragenyx Pharmaceutical
Chief Financial Officer
2019
Camille Bedrosian
Ultragenyx Pharmaceutical
Chief Medical Officer
2019
Thomas Kassberg
Ultragenyx Pharmaceutical